Case Reports
August 19, 2015
Vol. 82 No. 1 (2014): Cardiac series

Unexpected early obstruction of a biological aortic valve prosthesis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1084
Views
786
Downloads

Authors

A 64 years old male was submitted to the surgical substitution of a deteriorated biological aortic valve prosthesis with a new Hancock II biological prosthesis. The implantation was not followed by an anticoagulation or antiaggregation therapy. Two months later he was checked at our Institution because he complained symptoms and developed echocardiographic indexes suggestive of an aortic prosthesis obstruction by a clot. Both symptoms and the echocardiographic indexes of prosthesis obstruction faded away after giving warfarin; they arose again when the anticoagulation therapy was stopped and was replaced by aspirin. The following permanent use of warfarin normalized both clinic and echocardiographic aspects. The present case report underlines the utility of early controls after a biological prosthesis, yet aortic, implantation, when it is not followed by an anticoagulant therapy, also in subjects free from thrombosis high risk factors.

Altmetrics

Downloads

Download data is not yet available.

Citations

How to Cite



“Unexpected Early Obstruction of a Biological Aortic Valve Prosthesis”. 2015. Monaldi Archives for Chest Disease 82 (1). https://doi.org/10.4081/monaldi.2014.43.